Pharmaceutical industry – Page 52
-
Business
Return on drug R&D dropping
The pharma industry is getting less and less return on investment in R&D but trend seems to be bottoming out
-
Business
Baxter to pay $4bn for dialysis firm
Gambro makes products for hemodialysis and continuous renal replacement therapy
-
Business
Drug R&D costs rising
Review from UK consultancy suggests ten-fold increase in per medicine R&D costs over last 30 years
-
Business
GSK expands in India and Nigeria
Company has struck deals to increase ownership of subsidiaries
-
OpinionFull disclosure?
The pharma industry should be more open with its trial data, says Derek Lowe
-
Business
Roche and the Tamiflu data
Company position on access to data for antiviral Tamiflu (oseltamivir) tablets could be softening
-
BusinessRecord insider trading case hits pharma
US authorities claim that hedge fund manager made illicit gains of $276 million in response to confidential clinical trial data
-
Business
BASF bids €664m for omega-3 company
Pronova BioPharma makes pharmaceutical ingredients as well as nutritional supplements based in omega-3 fatty acids
-
Business
Reckitt steps into Schiff deal
Higher bid could sink Bayer’s $1.2bn attempt to buy vitamins and nutritional supplements company
-
BusinessWhat lies within
Bayer boss Marijn Dekkers aims to increase impact of good R&D across different internal units
-
Business
Takeda buys Envoy for $140m
The small US biotech will boost Takeda’s drug discovery efforts
-
Business
Approval for first gene therapy drug
Glybera (alipogene tiparvovec) injections have been approved in Europe
-
Business
Novartis biotech plant for Singapore
Firm will invest $500 million in biotech manafacturing
-
Opinion
High finance meets big pharma?
Derek Lowe examines an alternative funding model for pharmaceutical research
-
Business
Patent woes lead to sharp sales losses
Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs
-
Business
Pfizer to pay $700m for Ritalin re-formulated
Pfizer to buy a company with a liquid formulation of historic ADHD drug methylphenidate
-
News
GSK pledge on trials transparency
Pharma giant tackles critics by announcing that it will publish all clinical trials data regardless of the result
-
Business
Bayer and Evotec team up on endometriosis
German collaboration aims to develop three drug candidates in five years
-
Business
Teva pulls generic antidepressant
FDA rules that Budeprion XL is not equivalent to Wellbutrin XL